BR0313210A - Processos microbiológicos para a produção de 11alfa-hidróxi esteróides 7alfa-substituìdos - Google Patents

Processos microbiológicos para a produção de 11alfa-hidróxi esteróides 7alfa-substituìdos

Info

Publication number
BR0313210A
BR0313210A BR0313210-2A BR0313210A BR0313210A BR 0313210 A BR0313210 A BR 0313210A BR 0313210 A BR0313210 A BR 0313210A BR 0313210 A BR0313210 A BR 0313210A
Authority
BR
Brazil
Prior art keywords
production
steroids
substituted
7alpha
microbiological processes
Prior art date
Application number
BR0313210-2A
Other languages
English (en)
Inventor
Ludwig Zorn
Rolf Bohlmann
Norbert Gallus
Hermann K Nzer
Hans-Peter Muhn
Reinhard Nubbemeyer
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10233723A external-priority patent/DE10233723A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of BR0313210A publication Critical patent/BR0313210A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating
    • C12P33/08—Hydroxylating at 11 position
    • C12P33/10—Hydroxylating at 11 position at 11 alpha-position
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/12—Acting on D ring
    • C12P33/16—Acting at 17 position

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"PROCESSOS MICROBIOLóGICOS PARA A PRODUçãO DE 11ALFA-HIDRóXI ESTERóIDES 7ALFA-SUBSTITUìDOS". Um novo processo de síntese para a produção de produtos iniciais para a produção de compostos com a fórmula genérica (8,10,12) é descrito. Nesta síntese, compostos com fórmula genérica (4,B) são produzidos em uma reação microbiológica. Os significados de radicais R^ 7^, R^ 10^, R^ 11^, R^ 13^, R^ 17^ e R^ 17<39>^ assim como o grupo U-V-W-X-Y-Z são indicados nas reivindicações.
BR0313210-2A 2002-07-24 2003-07-24 Processos microbiológicos para a produção de 11alfa-hidróxi esteróides 7alfa-substituìdos BR0313210A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10233723A DE10233723A1 (de) 2002-07-24 2002-07-24 Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene
US40295302P 2002-08-14 2002-08-14
PCT/EP2003/008111 WO2004011663A2 (de) 2002-07-24 2003-07-24 Mikrobiologische verfahren zur herstellung von 7alpha-substituierten 11alpha-hydroxysteroiden

Publications (1)

Publication Number Publication Date
BR0313210A true BR0313210A (pt) 2005-06-28

Family

ID=31189296

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0313210-2A BR0313210A (pt) 2002-07-24 2003-07-24 Processos microbiológicos para a produção de 11alfa-hidróxi esteróides 7alfa-substituìdos

Country Status (20)

Country Link
EP (1) EP1523568A2 (pt)
JP (1) JP4417838B2 (pt)
KR (1) KR101041328B1 (pt)
CN (1) CN100339486C (pt)
BR (1) BR0313210A (pt)
CA (1) CA2492079C (pt)
CO (1) CO5690563A2 (pt)
CR (1) CR7672A (pt)
EA (2) EA008147B1 (pt)
EC (1) ECSP055630A (pt)
HK (1) HK1081999A1 (pt)
HR (1) HRP20050172A2 (pt)
IL (1) IL166358A0 (pt)
MX (1) MXPA05001024A (pt)
NO (1) NO20050980L (pt)
NZ (2) NZ537871A (pt)
PH (1) PH12005500143B1 (pt)
PL (1) PL373808A1 (pt)
RS (1) RS51855B (pt)
WO (1) WO2004011663A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200804405A (en) * 2005-10-27 2008-01-16 Taiho Pharmaceutical Co Ltd Process for production of steroid compound
CN103834712B (zh) * 2012-11-26 2016-03-30 复旦大学 去氧孕烯中间体纳米脂质体生物转化的优化方法
CN103214543B (zh) * 2012-12-25 2015-09-02 中国人民解放军海军医学研究所 新山楂酸衍生物、其制备方法及其在抗肿瘤药物中的应用
CN104862323B (zh) * 2015-06-02 2018-01-16 中国农业科学院生物技术研究所 修饰苯二酚类化合物的羟化酶基因

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL75841C (pt) 1949-06-11
US2658023A (en) * 1953-04-21 1953-11-03 Pfizer & Co C Oxygenation of steroids
US2985563A (en) * 1958-11-13 1961-05-23 Schering Corp 11alpha-hydroxylation of steroids by glomerella
US3004047A (en) * 1959-03-13 1961-10-10 Olin Mathieson 6alpha-halo-11alpha-hydroxy steroids of the pregnane series and esters thereof
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3203869A (en) * 1962-10-11 1965-08-31 Syntex Corp 11alpha-hydroxylation of 6-substituted-11-desoxy steroids with microorganisms of thegenus fusarium, liseola section
US5342834A (en) 1989-04-07 1994-08-30 The Population Council, Inc. Method for androgen supplementation
EP1167381A3 (en) * 1995-12-11 2004-09-29 G.D. Searle &amp; Co. Process for preparation of 7 alpha-carboxyl 9,11-epoxy steroids and Intermediates useful therein
ATE215606T1 (de) * 1995-12-12 2002-04-15 Akzo Nobel Nv Mikrobielle 11alpha-hydroxylierung von steroiden
GB9525194D0 (en) 1995-12-12 1996-02-07 Zeneca Ltd Pharmaceutical composition
US20020012694A1 (en) * 1997-09-17 2002-01-31 Alfred J. Moo-Young Transdermal administration of ment
US6767902B2 (en) 1997-09-17 2004-07-27 The Population Council, Inc. Androgen as a male contraceptive and non-contraceptive androgen replacement
US5952319A (en) 1997-11-26 1999-09-14 Research Triangle Institute Androgenic steroid compounds and a method of making and using the same
EP1267885B8 (en) 2000-02-15 2007-06-20 Bayer Schering Pharma Aktiengesellschaft Male contraceptive formulation comprising norethisterone and testosterone undecanoate
DE10104327A1 (de) * 2001-01-24 2002-07-25 Schering Ag 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate
JP2006502997A (ja) * 2002-07-25 2006-01-26 シエーリング アクチエンゲゼルシャフト アンドロゲン１１β‐ハロゲンステロイドおよびゲスタゲンを含有する組成物ならびにこの組成物に基づく男性用避妊薬

Also Published As

Publication number Publication date
ECSP055630A (es) 2005-04-18
EA200500224A1 (ru) 2005-08-25
MX260952B (pt) 2008-10-01
JP4417838B2 (ja) 2010-02-17
EA200601030A1 (ru) 2006-10-27
KR20050026507A (ko) 2005-03-15
JP2006503813A (ja) 2006-02-02
CO5690563A2 (es) 2006-10-31
NZ537871A (en) 2006-10-27
CA2492079A1 (en) 2004-02-05
WO2004011663A3 (de) 2004-07-15
CN100339486C (zh) 2007-09-26
KR101041328B1 (ko) 2011-06-14
EA010572B1 (ru) 2008-10-30
PH12005500143B1 (en) 2011-03-25
HRP20050172A2 (en) 2005-04-30
PL373808A1 (en) 2005-09-19
CA2492079C (en) 2012-01-10
AU2003281677A1 (en) 2004-02-16
RS20050045A (en) 2007-06-04
IL166358A0 (en) 2006-01-16
HK1081999A1 (en) 2006-05-26
CR7672A (es) 2006-05-29
EA008147B1 (ru) 2007-04-27
MXPA05001024A (es) 2005-05-16
CN1671858A (zh) 2005-09-21
EP1523568A2 (de) 2005-04-20
RS51855B (sr) 2012-02-29
NZ549529A (en) 2008-04-30
NO20050980L (no) 2005-02-23
WO2004011663A9 (de) 2004-05-06
WO2004011663A2 (de) 2004-02-05

Similar Documents

Publication Publication Date Title
BRPI0518647A2 (pt) processo para a produÇço de um composto, e, composto
TNSN05007A1 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof.
NO20051052L (no) Rutheniumkomplekser som (pre) katalysatorer for metatesereaksjoner
CY1114582T1 (el) Παραγωγα αλκυνυλιου ως ρυθμιστες μεταβολοτροπων υποδοχεων γλουταμινικου οξεος
CY1112495T1 (el) Κυτταροτοξικοι παραγοντες που περιλαμβανουν νεα παραγωγα τομαϋμυκινης
CY1109568T1 (el) Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων
BR0307432A (pt) Difluormetiltiazolilcarboxanilidas
BR0211169A (pt) Processo para preparação de derivados de amidina
HUP9900155A2 (hu) Eljárás szerves diszulfidok és poliszulfidok szintézisére
ES2335410T8 (es) Derivados de aminopropanol.
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
DK1644389T3 (da) Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger
SE0200843D0 (sv) Chemical compounds
BR0312593A (pt) Aciluréias substituìdas por uréia e uretano, processo para a sua produção e sua aplicação
BR0205683A (pt) Processo para a preparação de derivados de piperazina, e, mesilato de um composto
BR0313210A (pt) Processos microbiológicos para a produção de 11alfa-hidróxi esteróides 7alfa-substituìdos
ATE353884T1 (de) Multifunktionelle kationische photoinitiatoren, deren herstellung und verwendung
TW200716555A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
BR0314128A (pt) Processo para o preparo de intermediários uteis para a sìntese de inibidores de tubulina
RS88704A (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
ATE415404T1 (de) Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2232 DE 15/10/2013.